| scholarly article | Q13442814 |
| P2093 | author name string | Ling Wei | |
| Shan Ping Yu | |||
| Xinyang Hu | |||
| Jamie L Fraser | |||
| Zhong-Yang Lu | |||
| P2860 | cites work | Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo | Q24678892 |
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Adult rat and human bone marrow stromal cells differentiate into neurons | Q28142919 | ||
| B cells and professional APCs recruit regulatory T cells via CCL4 | Q28204573 | ||
| IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking | Q28208563 | ||
| Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats | Q28209989 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Mesenchymal stem cells as trophic mediators | Q29619806 | ||
| Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. | Q33761185 | ||
| Ischemic rat brain extracts induce human marrow stromal cell growth factor production | Q34174635 | ||
| Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art | Q34271229 | ||
| Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning | Q34545459 | ||
| Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB | Q34762478 | ||
| Microglia as a source and target of cytokines | Q34963658 | ||
| Inflammatory mechanisms after ischemia and stroke | Q35063650 | ||
| Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation | Q35159463 | ||
| Marrow stromal cell transplantation in stroke and traumatic brain injury | Q35986798 | ||
| Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system | Q36107452 | ||
| Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin | Q36329696 | ||
| Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: progress and uncertainties | Q36512208 | ||
| Bone marrow stromal cells for repair of the spinal cord: towards clinical application | Q36687134 | ||
| Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses | Q36936307 | ||
| Stem cells and neurological diseases. | Q37053159 | ||
| Therapeutic strategy of erythropoietin in neurological disorders | Q37232882 | ||
| Genetic modification of ex-vivo expanded stem cells for clinical application | Q37761968 | ||
| Mesenchymal stem cells: new approaches for the treatment of neurological diseases | Q37763242 | ||
| Mesenchymal Stem Cells: Mechanisms of Inflammation | Q37809081 | ||
| Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia | Q40433759 | ||
| Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis | Q42503360 | ||
| Primed for lethal battle: a step forward to enhance the efficacy and efficiency of stem cell transplantation therapy | Q42576311 | ||
| Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats | Q43770920 | ||
| Hypoxia-inducible factor in brain | Q43957029 | ||
| Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 | ||
| Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model | Q45178238 | ||
| Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols | Q46584012 | ||
| Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats | Q46925001 | ||
| BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. | Q47226339 | ||
| Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovasc | Q47590872 | ||
| Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells | Q48497907 | ||
| Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice | Q48557851 | ||
| Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis | Q50640546 | ||
| Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. | Q51710249 | ||
| Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha | Q64378540 | ||
| Role of angiogenesis in patients with cerebral ischemic stroke | Q71643306 | ||
| Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization | Q73106062 | ||
| [Frontal lobe dysfunction in patients with epilepsy and chronic psychosis] | Q73541768 | ||
| Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis | Q74265704 | ||
| The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats | Q80313211 | ||
| Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells | Q80593656 | ||
| In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain | Q80718572 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | hypoxia | Q105688 |
| angiogenesis | Q539568 | ||
| bone marrow | Q546523 | ||
| mesenchymal stem cell | Q1922379 | ||
| cerebral infarction | Q1209150 | ||
| neurogenesis | Q1456827 | ||
| P304 | page(s) | 635-645 | |
| P577 | publication date | 2012-03-09 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats | |
| P478 | volume | 46 |
| Q36679690 | 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose-Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis |
| Q42464603 | 3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney |
| Q90599623 | Activated Mesenchymal Stem Cells Induce Recovery Following Stroke Via Regulation of Inflammation and Oligodendrogenesis |
| Q90181629 | Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment |
| Q48576230 | Angiogenesis contributes to the neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats |
| Q95841416 | BM-MSC Transplantation Alleviates Intracerebral Hemorrhage-Induced Brain Injury, Promotes Astrocytes Vimentin Expression, and Enhances Astrocytes Antioxidation via the Cx43/Nrf2/HO-1 Axis |
| Q28069791 | Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells |
| Q41767679 | Bone Marrow Mesenchymal Stem Cells Enhance the Differentiation of Human Switched Memory B Lymphocytes into Plasma Cells in Serum-Free Medium |
| Q35166316 | Bone Marrow-Derived Mesenchymal Stem Cells Repair Necrotic Pancreatic Tissue and Promote Angiogenesis by Secreting Cellular Growth Factors Involved in the SDF-1 α /CXCR4 Axis in Rats |
| Q51743475 | Bone marrow mesenchymal stem cell-derived microvesicles protect rat pheochromocytoma PC12 cells from glutamate-induced injury via a PI3K/Akt dependent pathway. |
| Q38210965 | Bone marrow stromal cells as a therapeutic treatment for ischemic stroke |
| Q90325365 | Bone marrow-derived mesenchymal stem cell and simvastatin treatment leads to improved functional recovery and modified c-Fos expression levels in the brain following ischemic stroke |
| Q41581721 | CXCL12 overexpression promotes the angiogenesis potential of periodontal ligament stem cells |
| Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
| Q38529630 | Cerebral Ischemic Preconditioning: the Road So Far…. |
| Q41916586 | Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells. |
| Q36711673 | Challenges and opportunities for stem cell therapy in patients with chronic kidney disease |
| Q34400694 | Conserved dopamine neurotrophic factor-transduced mesenchymal stem cells promote axon regeneration and functional recovery of injured sciatic nerve |
| Q55039453 | Curative effects of GM1 in the treatment of severe ischemic brain injury and its effects on serum TNF-α and NDS. |
| Q42997205 | Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem cells. |
| Q37554021 | Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function. |
| Q50565602 | Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats |
| Q48828024 | Delayed ALK5 inhibition improves functional recovery in neonatal brain injury |
| Q48345489 | Delayed treatment of 6-Bromoindirubin-3'-oxime stimulates neurogenesis and functional recovery after focal ischemic stroke in mice |
| Q37615057 | Effect of Hypoxia on the Differentiation and the Self-Renewal of Metanephrogenic Mesenchymal Stem Cells. |
| Q41844499 | Effect of bone marrow stromal cell transplantation on neurologic function and expression of VEGF in rats with focal cerebral ischemia |
| Q46394024 | Effect of hypoxia on generation of neurospheres from adipose tissue-derived canine mesenchymal stromal cells |
| Q48685893 | Effects of BDNF-Transfected BMSCs on Neural Functional Recovery and Synaptophysin Expression in Rats with Cerebral Infarction |
| Q51013583 | Effects of SDF-1/CXCR4 on the Repair of Traumatic Brain Injury in Rats by Mediating Bone Marrow Derived Mesenchymal Stem Cells. |
| Q35992648 | Effects of bone marrow mesenchymal stem cells (BM-MSCs) on rat pial microvascular remodeling after transient middle cerebral artery occlusion |
| Q35050306 | Effects of bone marrow-derived mesenchymal stem cells on the axonal outgrowth through activation of PI3K/AKT signaling in primary cortical neurons followed oxygen-glucose deprivation injury |
| Q47910636 | Electrical preconditioning of stem cells with a conductive polymer scaffold enhances stroke recovery |
| Q38685319 | Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia |
| Q47753930 | Exogenous and endogenous therapeutic effects of combination Sodium Ferulate and bone marrow stromal cells (BMSCs) treatment enhance neurogenesis after rat focal cerebral ischemia |
| Q58796976 | Exosomes Derived from miR-214-Enriched Bone Marrow-Derived Mesenchymal Stem Cells Regulate Oxidative Damage in Cardiac Stem Cells by Targeting CaMKII |
| Q27692601 | Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke? |
| Q37204506 | G-CSF and hypoxic conditioning improve the proliferation, neural differentiation and migration of canine bone marrow mesenchymal stem cells |
| Q47405412 | Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell |
| Q33708436 | HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury |
| Q57767255 | HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia |
| Q36209962 | Heparin-binding epidermal growth factor-like growth factor protects mesenchymal stem cells |
| Q53314671 | High content and high throughput screening to assess the angiogenic and neurogenic actions of mesenchymal stem cells in vitro. |
| Q42154661 | Hormesis, cell death, and regenerative medicine for neurode-generative diseases |
| Q64074854 | Human stem cells transplanted into the rat stroke brain migrate to the spleen via lymphatic and inflammation pathways |
| Q35082645 | Humoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders |
| Q35196216 | Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotection |
| Q34559310 | Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease |
| Q24613344 | Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration |
| Q35805322 | Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis |
| Q42773071 | Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities |
| Q48494780 | Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release |
| Q60048546 | Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic Efficacy |
| Q48218622 | Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model. |
| Q35779127 | Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro |
| Q89401057 | Hypoxic Preconditioning of Mesenchymal Stem Cells with Subsequent Spheroid Formation Accelerates Repair of Segmental Bone Defects |
| Q58796484 | Hypoxic preconditioned bone mesenchymal stem cells ameliorate spinal cord injury in rats via improved survival and migration |
| Q38687037 | Hypoxic preconditioning of myoblasts implanted in a tissue engineering chamber significantly increases local angiogenesis via upregulation of myoblast vascular endothelial growth factor-A expression and downregulation of miRNA-1, miRNA-206 and angio |
| Q34095735 | Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction |
| Q39474453 | In Vivo Vascularization of Endothelial Cells Derived from Bone Marrow Mesenchymal Stem Cells in SCID Mouse Model |
| Q35837970 | In vivo tracking of human adipose-derived stem cells labeled with ferumoxytol in rats with middle cerebral artery occlusion by magnetic resonance imaging. |
| Q90216409 | In vivo tracking of intravenously injected mesenchymal stem cells in an Alzheimer's animal model |
| Q49617810 | Injectable co-gels of collagen and decellularized vascular matrix improve MSC-based therapy for acute kidney injury |
| Q35396013 | Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats |
| Q42697924 | Intra-arterial transplantation of human bone marrow mesenchymal stem cells (hBMMSCs) improves behavioral deficits and alters gene expression in rodent stroke model |
| Q50241138 | Intracranial Transplantation of Hypoxia-Preconditioned iPSC-Derived Neural Progenitor Cells Alleviates Neuropsychiatric Defects After Traumatic Brain Injury in Juvenile Rats |
| Q48346065 | Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats |
| Q37653638 | Ion channels in regulation of neuronal regenerative activities |
| Q46271091 | Mesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies. |
| Q60046871 | Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning |
| Q28066324 | Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke |
| Q38287785 | Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application |
| Q27324791 | Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice |
| Q57181886 | Neural Differentiation of Bone Marrow Mesenchymal Stem Cells Carrying the FTH1 Reporter Gene and Detection with MRI |
| Q36262326 | Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion |
| Q37402374 | Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat. |
| Q41026038 | Neuroprotective Effects of Stem Cells in Ischemic Stroke |
| Q36030863 | Obstructive sleep apnea and adverse outcomes in surgical and nonsurgical patients on the wards. |
| Q38353261 | Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. |
| Q39155818 | Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice |
| Q34993029 | Oxygen tension variation in ischemic gastrocnemius muscle, marrow, and different hypoxic conditions in vitro |
| Q47825309 | Potential benefits of mesenchymal stem cells and electroacupuncture on the trophic factors associated with neurogenesis in mice with ischemic stroke. |
| Q36087909 | Potential role of adult stem cells in obstructive sleep apnea |
| Q47697669 | Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. |
| Q35949645 | Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats |
| Q37628982 | Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential |
| Q31153106 | Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential |
| Q37607849 | Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. |
| Q33998015 | Preconditioning stem cells for in vivo delivery. |
| Q38126494 | Preconditioning strategy in stem cell transplantation therapy |
| Q30732873 | Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion |
| Q42267329 | Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy |
| Q93066172 | Priming with erythropoietin enhances cell survival and angiogenic effect of mesenchymal stem cell implantation in rat limb ischemia |
| Q33881497 | Prospectively isolated mesenchymal stem/stromal cells are enriched in the CD73+ population and exhibit efficacy after transplantation |
| Q41373565 | Rapid and efficient generation of neural progenitors from adult bone marrow stromal cells by hypoxic preconditioning |
| Q91646519 | Recent Advances in Mono- and Combined Stem Cell Therapies of Stroke in Animal Models and Humans |
| Q37580911 | Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats |
| Q91955573 | Regeneration after stroke: Stem cell transplantation and trophic factors |
| Q38539382 | Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies |
| Q45977749 | Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. |
| Q58802961 | Reversibly immortalized hepatic progenitor cell line containing double suicide genes |
| Q28079830 | Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage |
| Q38206195 | Role of vascular endothelial growth factor and other growth factors in post-stroke recovery |
| Q37133173 | Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemia |
| Q38742380 | Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke |
| Q41928171 | Stem cell-based therapies for ischemic stroke |
| Q34652636 | Stem cells of the apical papilla regulate trigeminal neurite outgrowth and targeting through a BDNF-dependent mechanism |
| Q26747501 | Strategies to Optimize Adult Stem Cell Therapy for Tissue Regeneration |
| Q52889336 | Stroke Serum Priming Modulates Characteristics of Mesenchymal Stromal Cells by Controlling the Expression miRNA-20a. |
| Q37009359 | Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury |
| Q38133632 | Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system. |
| Q38802641 | The Cytoprotective Effects of Human Endothelial Progenitor Cell-Conditioned Medium Against an Ischemic Insult Are Not Dependent on VEGF and IL-8. |
| Q38835646 | The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke |
| Q28068736 | The Neurovascular Properties of Dental Stem Cells and Their Importance in Dental Tissue Engineering |
| Q50655213 | The effect of hypoxia preconditioning on the neural and stemness genes expression profiling in human umbilical cord blood mesenchymal stem cells |
| Q49807176 | The effects of intermittent whole-body hypoxic preconditioning on patients with carotid artery stenosis |
| Q41573021 | The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits |
| Q38488511 | The role of the microenvironment on the fate of adult stem cells |
| Q88696073 | The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke |
| Q92738249 | Therapeutic effect of transplantation of human bone marrow‑derived mesenchymal stem cells on neuron regeneration in a rat model of middle cerebral artery occlusion |
| Q39455373 | Therapeutic potential of mesenchymal stem cells for diabetes |
| Q55221537 | Three-Dimensional Graphene-RGD Peptide Nanoisland Composites That Enhance the Osteogenesis of Human Adipose-Derived Mesenchymal Stem Cells. |
| Q87041085 | Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke |
| Q35779905 | Tracking the Fate of Muscle-derived Stem Cells: an Insight into the Distribution and Mode of Action |
| Q55025648 | Transplantation of Hypoxic-Preconditioned Bone Mesenchymal Stem Cells Retards Intervertebral Disc Degeneration via Enhancing Implanted Cell Survival and Migration in Rats. |
| Q45498139 | Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse |
| Q47101441 | Transplantation of iPS cell-derived neural progenitors overexpressing SDF-1α increases regeneration and functional recovery after ischemic stroke |
| Q48253324 | Transplantation with hypoxia-preconditioned mesenchymal stem cells suppresses brain injury caused by cardiac arrest-induced global cerebral ischemia in rats. |
| Q64322389 | Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke |
| Q38998166 | Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. |
| Q38139296 | Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke |
| Q38181868 | Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases |
| Q37697685 | VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells |
| Q34745357 | Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice |
Search more.